Investing in Software (Web Marketplace Saas..) &b... Berlin, Germany
$30000000 (Early stage VC)
$22000000 (Later stage VC)
$16000000 (Early stage VC)
$12000000 (Later stage VC)
• ShapeShift AG:
$10400000 (Early stage VC)
• Curio (Publishing):
$9000000 (Early stage VC)
• Alesi Surgical:
$6000000 (Later stage VC)
$5400000 (Later stage VC)
$5000000 (Later stage VC)
$4660000 (Early stage VC)
• Energy Robotics:
$2440000 (Seed Round)
• DCS FAST LINK (dcs plus):
(Later stage VC)
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • Blockchain (& Cryptos) • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Investment Management • Mobile • Online Social
Dr. Christian Nagel is a Co-Founder and serves as Managing Partner at Earlybird Venture Capital. He also serves as the Chairman of the Supervisory Board at Paddle8 and XAIN. He is also the chairman at International Venture Club. He has several years of experience as an investor and entrepreneur, focusing on web-enabled services and gaming. His most successful exits are Tipp24 (IPO Prime Standard FSE: TIM); Interhyp (IPO Prime Standard FSE: IYP), and Trade Sale BridgeCo to SMSC (NASDAQ: SMSC). He was a Board Member at Auctionata, madvertise, Smava and Versus. He was a co-founder and managing partner of SMB Industrieholding Wildau and DH Industrieholding Hohenthurm and a consultant for McKinsey & Company. He holds an MSc from Technical University of Hamburg and PHD from University of St. Gallen.
Marc Rougier is a Co-Founder and serves as President at Scoop.it. Rougier also serves as Partner at Elaia Partners. His first entrepreneurial experience dates back to 1990 when he left his PhD program in Artificial Intelligence at McGill University to launch his first start-up (Logic Controller Management). He then joined Thales as an international business developer in Australia, Asia, Africa and America. In 2000, he launched his second start-up, Meiosys (Application Virtualisation), that moved to Palo Alto and was then acquired by IBM in 2005. After two years in corporate development at IBM, he launched Goojet, a mobile social media. He serves as board member at OpenIO, Containous, Stanley Robotics, ForePaaS and Uwinloc.
Trying to help the world's most disruptive companies reach their full potential via Atomico, where I am the founding Partner and CEO. Atomico invests in disruptive technology companies with ambitious founders from Series A onwards. Our experienced team includes entrepreneurs and executives from the world's most successful technology firms who partner with our companies as they scale to become global winners.
I am also engaged in the fight against climate change and saving the Baltic sea through Zennström Philanthropies.
Specialties: Building companies
Investing and helping companies
Investing in early-stage B2B software companies, no matter where they start from.Would love to hear from you: email@example.com Point Nine is a VC firm started >10 years ago and focused on early-stage investments. We invest in 10-15 new companies every year and have now invested in 150+ startups such as Algolia, Loom, Contentful, Typeform, Sqreen, Mambu, Chainalysis, Nexhealth, cargo.one, PlayPlay, Revolut and many other great companies that we call the P9 Family.My conviction is that technology drives growth and advancement and my academic and professional choices so far have been led by this willingness to work in/with companies which use technology to generate disruptive new businesses ideas that can positively disrupt the world.
Director at Northstar Ventures, an early stage venture capital firm based in the North East of England. We back talented people with the potential to build innovative, high growth businesses, particularly in the technology sector. Our interests include mobile, internet, IoT, digital media, enterprise software and medtech.We also have a team focused on social investment and, where possible, look to achieve a positive social impact through our investment activity.
Supply chain finance
Real estate tech, particularly appraisals and home finance
Enterprise payouts / mass disbursements
Not Interested In
Companies selling signal to the buyside
Insurance aggregator models
Typically, companies dependent on enterprise-level sales into banks
Investing in Software (Web Marketplace Saas..) &b... Paris France , Paris ..., France
$32000000 (Later stage VC)
• In & Motion:
$11940000 (Later stage VC)
$7460000 (Early stage VC)
$2560000 (Seed Round)
Paris France - Paris (France), France
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • FinTech (& Financials services) • Energy • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction)
Mr Rencurel started his carrer at BNP Paribas as branch manager and later joined the internal audit department of the group, where for four years he conducted audits in France and abroad. Then he joined Banexi, the BNP Paribas group’s investment bank, as Vice President of the communications industries department and started working on the first ETMF fund generation at that time.
He is also a professor at the Sorbonne in the Institut d’Administration des Entreprises’ Financial and Tax Engineering postgraduate diploma program. Mr Rencurel gives seminars on private equity for chartered accountants in the KPMG network of firms. He holds a Master’s degree in econometrics and monetary economics from the Université de Paris Dauphine.
With nearly $2 billion of capital under management, Water Street Healthcare Partners is a Chicago-based private equity firm focused on healthcare companies. Water Street seeks investments and relationships in targeted sectors across a wide spectrum of the healthcare industry (Diagnostic Devices, Medical Products, Pharmaceutical Services, Specialty Distribution, Specialty Pharmaceuticals, Specialty Services). The firm specializes in creating market leaders through flexible transaction structures, with particular expertise in complex corporate partnerships, carve-outs and recapitalizations in which owners retain a significant ownership stake. Transactions typically range from $50 million to $500 million. Water Street focuses primarily on two groups: large corporations that have low-priority business units or subsidiaries, and middle market healthcare companies where management wants to significantly accelerate growth and value creation. The firm does not typically invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow.